NDC properties for "Tepylute" (RxCUI 2700712)
About this data
The tables show NDC propoerties for Tepylute with the RxCUI 2700712
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Tepylute (RxCUI 2700712)
| NDA | NDA216984 |
|---|---|
| RxCUI | 2700712 |
| SPL_SET_ID | add44e98-a042-4e38-b870-beb36693805b |
| Prescribable Synonym | Tepylute 15 MG in 1.5 ML Injection |
| RXNAV_STR | Tepylute 15 MG per 1.5 ML Injection |
| RxNorm Name | 1.5 ML thiotepa 10 MG/ML Injection [Tepylute] |
| RxNorm Synonym | 1.5 ML TSPA 10 MG/ML Injection [Tepylute] |
| RxNorm Synonym | Tepylute 10 MG/ML per 1.5 ML Injection |
| RxNorm Synonym | Tepylute 15 MG per 1.5 ML Injection |
| Related queries | Interactions (for RxCUI 2700712) |
NDC Properties
NDC Item 81927010501
| NDC 9 | 81927-105 |
|---|---|
| NDC 10 | 81927-105-01 |
| NDC Item | 81927010501 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (81927-105-01) / 1.5 mL in 1 VIAL, SINGLE-DOSE |
| FDA SPL set id | 867584 |
| Labeler | Shorla Oncology Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2025-03-31 |
| Marketing status | ACTIVE |
| NDA | NDA216984 |
| Related queries | Properties for NDC 9 81927-105 |